L vs MPLT · P/E 14, rev $18.45B vs $1.24B cap
Loews Corp (L) versus MapLight Therapeutics, Inc. Common Stock (MPLT) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
MPLT does not have a complete income-statement cache yet.
L currently screens at market cap $22.36B and trailing P/E 13.8. MPLT currently screens at market cap $1.24B.
Not investment advice. Open the L and MPLT stock pages for the full models.
Not investment advice.